Longevity Wellness Pharmaceutical Market Growth, Analysis Industry Outlook & Region Forecast Analysis By Fact.MR
Rockville, Maryland, United States – September 22, 2026 – Longevity drug development is increasingly moving toward clinically defined diseases and measurable biological endpoints rather than broad claims about extending human life. Insilico Medicine's investigational drug rentosertib, currently in Phase 3 development for idiopathic pulmonary fibrosis, is being evaluated...
0 Σχόλια 0 Μοιράστηκε 8 Views 0 Προεπισκόπηση
Urh Social https://urh.app